Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
Hsu PY, Liang PC, Chang WT, Lu MY, Wang WH, Chuang SC, Wei YJ, Jang TY, Yeh ML, Huang CI, Lin YH, Wang CW, Hsieh MY, Hou NJ, Hsieh MH, Tsai YS, Ko YM, Lin CC, Chen KY, Dai CY, Lin ZY, Chen SC, Chuang WL, Huang CF, Huang JF, Yu ML.
Hsu PY, et al. Among authors: ko ym.
Am J Cancer Res. 2022 Dec 15;12(12):5576-5588. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 36628276
Free PMC article.